PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

We retrospectively analyzed PDL1 mRNA expression in 306 breast cancer samples, including 112 samples of an aggressive form, inflammatory breast cancer (IBC). PDL1 expression was heterogeneous, but was higher in IBC than in non-IBC. Compared to normal breast samples, PDL1 was overexpressed in 38% of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Bertucci, François, Finetti, Pascal, Colpaert, Cécile, Mamessier, Emilie, Parizel, Maxime, Dirix, Luc, Viens, Patrice, Birnbaum, Daniel, van Laere, Steven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537030/
https://ncbi.nlm.nih.gov/pubmed/25940795
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak